A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD

References

• Pankratz N, Foroud T. Genetics of Parkinson disease. Genet Med 2007;9:801–11.
   PubMed Web of Science ®Google Scholar
• Keyser RJ, Oppon E, Carr JA, et al. Identification of Parkinson's disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson's disease patients. J Neural Transm 2011;118:889–97.
   PubMed Web of Science ®Google Scholar
• Poehler AM, Xiang W, Spitzer P, et al. Autophagy modulates SNCA/alpha-synuclein release, thereby generating a hostile microenvironment. Autophagy 2014:e36436.
   Google Scholar
• Deng S, Deng X, Yuan L, et al. Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease. Acta Neurol Belg 2014. DOI: 10.1007/s13760-014-0347-2
   PubMed Web of Science ®Google Scholar
• Mata IF, Leverenz JB, Weintraub D, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol 2014;71:1405–12.
   PubMed Web of Science ®Google Scholar
• Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 2004;56:331–49.
   PubMed Web of Science ®Google Scholar
• Dorszewska J, Prendecki M, Oczkowska A, et al. Polymorphism of the COMT, MAO, DAT, NET and 5-HTT genes, and biogenic amines in Parkinson's disease. Curr Genom 2013;14:518–33.
   PubMed Web of Science ®Google Scholar
• Nolen WA, Hoencamp E, Bouvy PF, et al. Reversible monoamine oxidase-A inhibitors in resistant major depression. Clin Neuropharmacol 1993;16(Suppl 2):S69–76.
   PubMed Web of Science ®Google Scholar
• Kaludercic N, Carpi A, Nagayama T, et al. Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. Antioxid Redox Signal 2014;20:267–80.
   PubMed Web of Science ®Google Scholar
• Tan EK, Khajavi M, Thornby JI, et al. Variability and validity of polymorphism association studies in Parkinson's disease.Neurology 2000;55:533–8.
   PubMed Web of Science ®Google Scholar
• Montag C, Jurkiewicz M, Reuter M. The role of the catechol-O-methyltransferase (COMT) gene in personality and related psychopathological disorders. CNS Neurol Disord Drug Targets 2012;11:236–50.
   PubMed Web of Science ®Google Scholar
• Grossman MH, Emanuel BS, Budarf ML. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1—-q11.2. Genomics 1992;12:822–5.
   PubMed Web of Science ®Google Scholar
• Lachman HM, Papolos DF, Saito T, et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996;6:243–50.
   PubMedGoogle Scholar
• Morimoto Y, Murayama N, Kuwano A, et al. Association analysis of a polymorphism of the monoamine oxidase B gene with Parkinson's disease in a Japanese population. Am J Med Genet 1995;60:570–2.
   PubMed Web of Science ®Google Scholar
• Ho SL, Kapadi AL, Ramsden DB, et al. An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 1995;37:403–5.
   PubMed Web of Science ®Google Scholar
• Costa P, Checkoway H, Levy D, et al. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 1997;74:154–6.
   PubMed Web of Science ®Google Scholar
• Hwang WJ, Lai ML, Tsai TT, et al. Genetic polymorphism of monoamine oxidase B and susceptibility of Parkinson's disease. Zhonghua Yi Xue Za Zhi (Taipei) 1997;60:137–41.
   PubMedGoogle Scholar
• Mellick GD, Buchanan DD, McCann SJ, et al. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mov Disord 1999;14:219–24.
   PubMed Web of Science ®Google Scholar
• Wu RM, Cheng CW, Chen KH, et al. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese. Neurology 2001;56:375–82.
   PubMed Web of Science ®Google Scholar
• Hernán MA, Checkoway H, O’Brien R, et al. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Neurology 2002;58:1381–7.
   PubMed Web of Science ®Google Scholar
• Kelada SN, Costa-Mallen P, Costa LG, et al. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease. Neurotoxicology 2002;23:515–9.
   PubMed Web of Science ®Google Scholar
• Tan EK, Chai A, Lum SY, et al. Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: a study in an Asian population. Am J Med Genet B Neuropsychiatr Genet 2003;120B:58–62.
   PubMed Web of Science ®Google Scholar
• Bialecka M, Klodowska-Duda G, Honczarenko K, et al. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease. Parkinsonism Relat Disord 2007;13:224–9.
   PubMed Web of Science ®Google Scholar
• Gu Z, Feng X, Dong X, et al. Smoking, genes encoding dopamine pathway and risk for Parkinson's disease. Neurosci Lett 2010;482:31–4.
   PubMed Web of Science ®Google Scholar
• Kiyohara C, Miyake Y, Koyanagi M, et al. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population. BMC Neurol 2011;11:89.
   PubMed Web of Science ®Google Scholar
• Torkaman-Boutorabi A, Ali Shahidi G, Choopani S, et al. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population. Folia Neuropathol 2012;50:382–9.
   PubMed Web of Science ®Google Scholar
• Kumudini N, Umai A, Devi YP, et al. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.Indian J Biochem Biophys 2013;50:436–41.
   PubMed Web of Science ®Google Scholar
• Tipton KF, Boyce S, O’Sullivan J, et al. Monoamine oxidases: certainties and uncertainties. Curr Med Chem 2004;11:1965–82.
   PubMed Web of Science ®Google Scholar
• Sun J, Jayathilake K, Zhao Z, et al. Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia. Psychiatry Res 2012;198:202–6.
   PubMed Web of Science ®Google Scholar
• Grant P, Gabriel F, Kuepper Y, et al. Psychosis-proneness correlates with expression levels of dopaminergic genes. Eur Psychiatry 2014;29:304–6.
   PubMed Web of Science ®Google Scholar
• Bergen SE, Fanous AH, Walsh D, et al. Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features. Schizophr Res 2009;109:94–7.
   PubMed Web of Science ®Google Scholar
• Alonso-Navarro H, Jimenez-Jimenez FJ, Garcia-Martin E, et al. Genomic and pharmacogenomic biomarkers of Parkinson's disease. Curr Drug Metab 2014;15:129–81.
   PubMed Web of Science ®Google Scholar
• Kurth JH, Kurth MC, Poduslo SE, et al. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993;33:368–72.
   PubMed Web of Science ®Google Scholar
• Fowler JS, Volkow ND, Wang GJ, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996;379:733–6.
   PubMed Web of Science ®Google Scholar
• Khalil AA, Steyn S, Castagnoli N, Jr. Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves. Chem Res Toxicol 2000;13:31–5.
   PubMed Web of Science ®Google Scholar
• Hauptmann N, Shih, JC. 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity. Life Sci 2001;68:1231–41.
   PubMed Web of Science ®Google Scholar